Catherine S. Murphy

1.0k total citations
9 papers, 856 citations indexed

About

Catherine S. Murphy is a scholar working on Genetics, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Catherine S. Murphy has authored 9 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 4 papers in Molecular Biology and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Catherine S. Murphy's work include Estrogen and related hormone effects (9 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Steroid Chemistry and Biochemistry (2 papers). Catherine S. Murphy is often cited by papers focused on Estrogen and related hormone effects (9 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Steroid Chemistry and Biochemistry (2 papers). Catherine S. Murphy collaborates with scholars based in United States and United Kingdom. Catherine S. Murphy's co-authors include V. Craig Jordan, Wade V. Welshons, Michael Wolf, John J. Pink, Rick J. Koch, Gloria M. Calaf, V. Craig Jordan, R. MCCAGUE, Susan M. Langan-Fahey and Lorraine F. Meisner and has published in prestigious journals such as Endocrine Reviews, Molecular Pharmacology and Breast Cancer Research and Treatment.

In The Last Decade

Catherine S. Murphy

9 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine S. Murphy United States	8	540	342	213	127	114	9	856
Lorri L. Short United States	12	514 1.0×	249 0.7×	198 0.9×	81 0.6×	70 0.6×	18	1.0k
Tomas Barkhem Sweden	9	636 1.2×	411 1.2×	197 0.9×	128 1.0×	60 0.5×	10	957
Brad Saville United States	7	618 1.1×	488 1.4×	194 0.9×	56 0.4×	133 1.2×	7	1.0k
Sylvie Bardon France	16	440 0.8×	478 1.4×	220 1.0×	37 0.3×	157 1.4×	22	1.1k
Larry J. Black United States	11	1.0k 1.9×	328 1.0×	283 1.3×	94 0.7×	120 1.1×	16	1.4k
Christina Tzagarakis-Foster United States	6	468 0.9×	290 0.8×	171 0.8×	186 1.5×	66 0.6×	9	708
Sara Antonia Li United States	21	590 1.1×	680 2.0×	262 1.2×	75 0.6×	213 1.9×	38	1.2k
Daniela Montanaro Italy	9	389 0.7×	344 1.0×	168 0.8×	55 0.4×	148 1.3×	10	856
George E. Swaneck United States	13	438 0.8×	369 1.1×	110 0.5×	55 0.4×	52 0.5×	18	784
Martin S. Hoagland United States	6	204 0.4×	320 0.9×	181 0.8×	114 0.9×	82 0.7×	7	647

Countries citing papers authored by Catherine S. Murphy

Since Specialization

Citations

This map shows the geographic impact of Catherine S. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine S. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine S. Murphy more than expected).

Fields of papers citing papers by Catherine S. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine S. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine S. Murphy. The network helps show where Catherine S. Murphy may publish in the future.

Co-authorship network of co-authors of Catherine S. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine S. Murphy. A scholar is included among the top collaborators of Catherine S. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine S. Murphy. Catherine S. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Murphy, Catherine S. & V. Craig Jordan. (1993). The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptor.. PubMed. 1(1-2). 65–82. 2 indexed citations

Murphy, Catherine S., et al.. (1991). Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.. Molecular Pharmacology. 39(3). 421–428. 32 indexed citations

Murphy, Catherine S., Susan M. Langan-Fahey, R. MCCAGUE, & V. Craig Jordan. (1990). Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.. Molecular Pharmacology. 38(5). 737–743. 62 indexed citations

Jordan, V. Craig & Catherine S. Murphy. (1990). Endocrine Pharmacology of Antiestrogens as Antitumor Agents*. Endocrine Reviews. 11(4). 578–610. 349 indexed citations

Murphy, Catherine S., John J. Pink, & V. Craig Jordan. (1990). Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.. PubMed. 50(22). 7285–92. 75 indexed citations

Murphy, Catherine S. & V. Craig Jordan. (1989). Structural components necessary for the antiestrogenic activity of tamoxifen. Journal of Steroid Biochemistry. 34(1-6). 407–411. 20 indexed citations

Murphy, Catherine S., et al.. (1989). Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture. European Journal of Cancer and Clinical Oncology. 25(12). 1777–1788. 44 indexed citations

Welshons, Wade V., Michael Wolf, Catherine S. Murphy, & V. Craig Jordan. (1988). Estrogenic activity of phenol red. Molecular and Cellular Endocrinology. 57(3). 169–178. 147 indexed citations

Welshons, Wade V., Catherine S. Murphy, Rick J. Koch, Gloria M. Calaf, & V. Craig Jordan. (1987). Stimulation of breast cancer cellsin vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Research and Treatment. 10(2). 169–175. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact